Literature DB >> 27494371

Dermatofibrosarcoma protuberans post basal cell carcinoma excision: A case report.

Aaron M Mullane1, Alexis Ricci2, Subhasis Misra3, Nail Aydin4.   

Abstract

INTRODUCTION: Dermatofibrosarcoma protuberans (DFSP) is a rare, malignant, soft tissue neoplasm of the dermis. Tumor recurrence is common following resection, and can be locally devastating if not identified in a timely manner. We report a unique case of this rare tumor. This case poses the question of an association between basal cell carcinoma (BCC) and DFSP, and presents the possible need for increased awareness of DFSP for healthcare providers and patients with a history of non-melanoma skin cancers as well as surgical or burn scars. PRESENTATION OF CASE: A 77-year-old male with a history of surgical excision of BCC presented with several palpable lesions in the superficial cutaneous tissue of the right anterior abdominal wall. Most of the lesions were consistent with lipoma; however, one lesion near the excision site of the BCC was more solid in consistency. The mass was removed with wide local excision encompassing all layers down to the abdominal fascia. Subsequent pathology findings included CD34 positive spindle cells in a whorled pattern consistent with DFSP. Resection margins were positive and a wide re-excision was performed with margins being negative. DISCUSSION: DFSP comprises approximately 0.01% of all malignant tumors. There are no known precipitating factors of DFSP, but its presence in surgical and burn scars is not uncommon. An association between DFSP and basal cell carcinoma has been suggested in the literature. Dermatofibroma and rarely DFSP may demonstrate basaloid proliferation of the overlying epidermis with characteristics of BCC. One case reporting coexistent DFSP and BCC located to the ear also suggested an association, but concluded that the finding was likely incidental due to sun exposure. In our case, the lesion's location is less routinely subjected to sun exposure and points more towards a possible association. The mainstay of treatment for local DFSP is wide local excision. Negative margins with the removal of fascia and muscle tissue as necessary is essential and the most significant prognostic factor. Three-dimensional reconstructions of DFSP have shown villous finger like projections of primary tumors, which is believed to be responsible for local recurrence. Recurrence can be devastating, as several cases have demonstrated rapid growth of remaining cells with increased morbidity following further resection.
CONCLUSION: Based on this case and those found in the literature, we believe an association may exist between DFSP and BCC and further study of this association is needed. DFSP is a rare malignancy unknown to many healthcare providers, but in the presence of increased awareness and physician vigilance in surgical resection and follow up, the potential morbidity of DFSP may be prevented.
Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Basal cell carcinoma; CD34; Case report; Dermatofibrosarcoma protuberans; Sarcoma

Year:  2016        PMID: 27494371      PMCID: PMC4976134          DOI: 10.1016/j.ijscr.2016.06.038

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

We report a unique case of a rare tumor, dermatofibrosarcoma protuberans (DFSP) at the site of previous basal cell carcinoma (BCC) excision. The patient presented to clinic out of concern for several palpable lesions on the right anterior abdominal wall. All but one lesion was consistent with lipoma, which was removed by wide local excision. Pathology returned with immunohistochemistry positivity for CD34, which is consistent with DFSP. One other case in the literature suggests an association between the two neoplasms. This case presents the need for increased awareness of DFSP and its management as well as the possible association with non-melanoma skin cancers and surgical or burn scars. DFSP is a rare, malignant, soft tissue neoplasm of the dermis. The clinical presentation of this tumor ranges from a single painless papule to an ulcerated nodule or plaque. Local recurrence of DFSP is common following primary resection, and can be locally devastating if not identified in a timely manner. We report a unique case of this tumor which suggests an association with BCC and presents the possible need for increased awareness of DFSP for healthcare providers and patients with a history of non-melanoma skin cancers, as well as surgical or burn scars.

Presentation of case

A 77-year-old male with a history of surgical excision of BCC seven years ago presented to the clinic out of concern for several palpable lesions in the superficial cutaneous tissue of the right anterior abdominal wall. Most of the lesions were consistent with lipoma; however, one lesion near the excision site of the BCC was more solid in consistency. The mass was removed with wide local excision encompassing all layers down to the abdominal fascia (Fig. 1). Subsequent pathology findings included immunohistochemistry positivity for CD34 (Fig. 2) and positive spindle cells in a whorled/storiform pattern consistent with DFSP (Fig. 3). Resection margins were positive and a wide re-excision was performed with margins being negative. The patient is currently being monitored as an outpatient without evidence of local recurrence.
Fig. 1

Gross Specimen.

Fig. 2

Immunohistochemistry, CD34.

Fig. 3

H&E stain of spindle cells in storiform pattern.

Discussion

DFSP comprises approximately 0.01% of all malignant tumors, and has an annual incidence of 4.2 per million population [1], [2]. Epidemiological studies have shown no genetic predisposition, almost equal sexual distribution, and no racial predilection. This tumor is seen most commonly in adults aged 20–50, but may present in individuals of all ages [3]. DFSP is often mistaken for lipoma, morphea, hypertrophic scars, dermatofibroma, and insect bites. The tumors may present as a single painless papule, non-indurated patch on the skin, or as an area of cutaneous thickening with red or bluish discoloration at the periphery. The lesion may enlarge into a lumpy nodule, ulcerate, hemorrhage, or possibly evolve into an atrophic/sclerotic plaque. It has been well demonstrated in the literature that the finding of DFSP in surgical and burn scars is a relatively common clinical presentation [4]. DFSP is routinely located to the trunk, with less common locations of the head and neck [5]. Metastasis is rare, with a rate of 4–6%, and if present, is most commonly to the lungs [6]. Due to the slow glowing nature of DFSP, diagnosis is often delayed up to several years. Histologically, the tumor cells have partial features of fibroblastic, histiocytic, and neuroectodermal cells, which suggests undifferentiated mesenchymal cells as a possible origin. DFSP is considered to be of low-grade malignancy and identified by a pattern of monomorphous spindle cells with a storiform or whorled pattern [7]. Positive immunohistochemistry for CD34 expression is consistently seen in DFSP and is often useful in differentiating DFSP from benign dermatofibroma and other soft tissue neoplasms [8]. The mainstay of treatment for local DFSP is wide local excision. Negative margins with the removal of fascia and muscle tissue as necessary is essential and the most significant prognostic factor of patients with DFSP. The local recurrence rate is just below 10% after extensive excision and around 50% when tumor margins are less than 3 cm5. Three-dimensional reconstructions of DFSP have shown villous finger like projections of primary tumors, which is believed to be responsible for local recurrence. Recurrence can be devastating, as several cases have demonstrated rapid growth of remaining cells with the increased morbidity of invasion into cutaneous and subcutaneous tissues following further resection [5], [9]. In the literature, an association between DFSP and basal cell carcinoma has been previously reported in one case. The authors of the case reported coexistent DFSP and BCC located to the ear. In this case, the finding was concluded to be more likely incidental, rather than causative, based on the location of the tumors on an area commonly subjected to sun-exposure [10]. However, in our case, the lesion was located on the anterior abdominal wall, an area less commonly subjected to sun-exposure. This aspect of the case points more towards an association between the two neoplasms than the previous report (Table 1).
Table 1

Timeline.

October, 2015Patient presented to clinic
November, 2015Lesion was removed with positive margins
November, 2015Margins further resected with negative margins
December, 2015Follow up appointment in clinic with no signs of recurrence.
March, 2016Follow up appointment in clinic with no signs of recurrence.
The pathophysiology of an association may be explained by the controversial finding that benign dermatofibroma and rarely DFSP, may demonstrate basaloid proliferation of the overlying epidermis with characteristics of BCC. This association has been hypothesized to be due to either induction of the overlying basaloid cells by the neoplasm or possibly reactive hyperplasia due to the compression of the cells through mass effect [10], [11].

Conclusion

An association between BCC and DFSP has been suggested previously in the literature, with only one other case reported. Based on this case, we support that an association may in fact exist and further study of this association is needed. DFSP is a rare malignancy unknown to many patients and healthcare providers. This tumors rarity, appearance that likens more common soft tissue and dermatologic conditions, and its capacity for devastating recurrence, places patients at risk. We believe this case presents the need for increased awareness of DFSP for healthcare providers and patients with a history of non-melanoma skin cancers as well as surgical or burn scars. With increased provider vigilance in patient identification, surgical excision with negative margins, and close follow-up, the potential morbidity with recurrence of this tumor can be successfully prevented.

Conflict of interest

None.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Ethical approval

Not applicable.

Consent

Yes, consent was obtained on the patient in this study.

Author contribution

Mr. Aaron Mullane–Involved in analysis of patient and literature, and also assisted with manuscript preparation and its approval. Ms. Alexis Ricci–Involved in analysis of patient and literature, and also assisted with manuscript preparation and its approval. Dr. Nail Aydin–Involved in treatment of patient. Conceived the project. Involved in analysis of patient and literature, and also assisted with manuscript preparation and its approval. Dr. Subhasis Misra–Involved in analysis of patient and literature, and also assisted with manuscript preparation and its approval.

Guarantor

Dr. Nail Aydin.
  10 in total

1.  Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread.

Authors:  D Ratner; C O Thomas; T M Johnson; V K Sondak; T A Hamilton; B R Nelson; N A Swanson; C Garcia; R E Clark; D J Grande
Journal:  J Am Acad Dermatol       Date:  1997-10       Impact factor: 11.527

2.  Basal cell carcinoma overlying a dermatofibroma: a revisited controversy.

Authors:  Aristóteles Rosmaninho; Pedro Farrajota; Carlos Peixoto; Isabel Amorim; Manuela Selores
Journal:  Eur J Dermatol       Date:  2011 Jan-Feb       Impact factor: 3.328

3.  Dermatofibrosarcoma protuberans and basal cell carcinoma.

Authors:  K Ibrahiem; J M Radhi
Journal:  Acta Derm Venereol       Date:  1998-05       Impact factor: 4.437

4.  Dermatofibrosarcoma protuberans arising in a BCG vaccination scar.

Authors:  J McLelland; T Chu
Journal:  Arch Dermatol       Date:  1988-04

5.  Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.

Authors:  D Monnier; C Vidal; L Martin; A Danzon; F Pelletier; E Puzenat; M P Algros; D Blanc; R Laurent; P H Humbert; F Aubin
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-11       Impact factor: 6.166

6.  Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002.

Authors:  Vincent D Criscione; Martin A Weinstock
Journal:  J Am Acad Dermatol       Date:  2006-12-01       Impact factor: 11.527

7.  Dermatofibrosarcoma protuberans: A case report of a rare, bulky tumor that was managed with surgical therapy.

Authors:  Ahmet Yılmaz; Erol Cenesizoglu; Ertuğrul Eğilmez; Safa Onel; Mehdi Muştu; Ahmet Cennet
Journal:  Int J Shoulder Surg       Date:  2009-01

8.  Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location.

Authors:  M J Kransdorf
Journal:  AJR Am J Roentgenol       Date:  1995-01       Impact factor: 3.959

Review 9.  Current treatment options in dermatofibrosarcoma protuberans.

Authors:  Doreen Lemm; L-O Mügge; T Mentzel; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-10       Impact factor: 4.553

10.  Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report.

Authors:  Francois G Kamar; Victor F Kairouz; Alain N Sabri
Journal:  Clin Sarcoma Res       Date:  2013-04-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.